orlistat vs glp 1 Lilly orforglipron oral GLP-1 phase 3 weight loss trial Orlistat and Mounjaro Together: Safety

In late-stage trials, people taking retatrutide have lost up to 28% of their body weight over a years time, the most impressive results seen for any weight loss drug to date

Supporting Weight Loss: Due to their appetite-suppressing effects, GLP-1 medications have been shown to support weight loss in individuals with type 2 diabetes and obesity

Food and Drug Administration in 2024 as a warning ( Retrospective cohort study of obese or T2DM patients reported cases showing no linkor even improvementin suicidality, with reduced risk of sudden or recurrent suicidal thoughts ( 5 State of the art and future directions No clear causal mechanism linking GLP-1 RA use to suicidality has been established

Recent research suggests that GLP-1 drugs may have promise in the treatment of cardiovascular disease, neurodegenerative disorders, and drug and alcohol addiction, among others